These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33632059)

  • 1. Zfx-induced upregulation of UBE2J1 facilitates endometrial cancer progression via PI3K/AKT pathway.
    Yang D; Ma X; Xu J; Jia K; Liu X; Zhang P
    Cancer Biol Ther; 2021 Mar; 22(3):238-247. PubMed ID: 33632059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K/AKT and MDM2/p53 signaling.
    Zhang P; Guo H; Zhao F; Jia K; Yang F; Liu X
    Open Med (Wars); 2023; 18(1):20220567. PubMed ID: 36852267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway.
    Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
    Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR‑494‑3p promotes the progression of endometrial cancer by regulating the PTEN/PI3K/AKT pathway.
    Zhu L; Wang X; Wang T; Zhu W; Zhou X
    Mol Med Rep; 2019 Jan; 19(1):581-588. PubMed ID: 30431102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IR-A/IGF-1R-mediated signals promote epithelial-mesenchymal transition of endometrial carcinoma cells by activating PI3K/AKT and ERK pathways.
    Wang C; Su K; Zhang Y; Zhang W; Zhao Q; Chu D; Guo R
    Cancer Biol Ther; 2019; 20(3):295-306. PubMed ID: 30426831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OTUB2 promotes the progression of endometrial cancer by regulating the PKM2-mediated PI3K/AKT signaling pathway.
    Zhang Q; Zhang J; Yao A; Tian X; Han Z; Yuan Y; Tao K; Yang X
    Cell Biol Int; 2023 Feb; 47(2):428-438. PubMed ID: 36316812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway.
    Wang Y; Yin L; Sun X
    J Exp Clin Cancer Res; 2020 Aug; 39(1):169. PubMed ID: 32847606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
    Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
    Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of long non-coding RNA OGFRP1 facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis and by activating PI3K/AKT/GSK-3β pathway.
    Lv Y; Chen S; Wu J; Lin R; Zhou L; Chen G; Chen H; Ke Y
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2083-2090. PubMed ID: 31131636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
    Qiao L; Dong C; Ma B
    J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
    Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
    Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinesin Family Member C1 (KIFC1) Accelerates Proliferation and Invasion of Endometrial Cancer Cells Through Modulating the PI3K/AKT Signaling Pathway.
    Zhou K; Zhao J; Qi L; He Y; Xu J; Dai M
    Technol Cancer Res Treat; 2020; 19():1533033820964217. PubMed ID: 33034273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOTTIP regulates progression of endometrial cancer via activating PI3K/AKT pathway.
    Guan Q; Zhang Q; Zhang C; Liu Q; Ren QL
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3727-3733. PubMed ID: 29949146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced PLOD2 regulates invasion and epithelial-mesenchymal transition in endometrial carcinoma cells.
    Wan J; Qin J; Cao Q; Hu P; Zhong C; Tu C
    Genes Genomics; 2020 Mar; 42(3):317-324. PubMed ID: 31872384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
    Zhang S; Wang M; Li Q; Zhu P
    Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic gene RGC-32 is a direct target of miR-26b and facilitates tongue squamous cell carcinoma aggressiveness through EMT and PI3K/AKT signalling.
    Yang ZH; Li J; Chen WZ; Kong FS
    Cell Biochem Funct; 2020 Oct; 38(7):943-954. PubMed ID: 32325539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA‑195 inhibits epithelial‑mesenchymal transition by targeting G protein‑coupled estrogen receptor 1 in endometrial carcinoma.
    Deng J; Wang W; Yu G; Ma X
    Mol Med Rep; 2019 Nov; 20(5):4023-4032. PubMed ID: 31545414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.